Vaxinano

About:

Vaxinano is a biotechnology company specialized in preclinical and pharmaceutical development of human

Twitter/X: vaxinano

Top Investors: Bpifrance, Eurasante, TCD Capital (ex TheClubDeal), WiSEED, Captech Santé

Description:

Vaxinano is a biotechnology company specialized in preclinical and pharmaceutical development of human and veterinary vaccines and drug delivery systems. Vaxinano was created in 2016, building on 25 years of research and clinical trials on vaccines and the patented technology of Pr Didier Betbeder.

Total Funding Amount:

6M EUR

Headquarters Location:

Lille, Nord-Pas-de-Calais, France

Founded Date:

2016-01-01

Contact Email:

contact(AT)vaxinano.com

Founders:

Didier Betbeder, Vincent Lemonnier

Number of Employees:

Last Funding Date:

2024-10-29

IPO Status:

Private

Industries: